Which closed-end funds own Gilead Sciences Inc?
17 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $161M. Security type: common equity. Country: United States. CUSIP 375558103 · ISIN US3755581036 · ticker GILD.
Holdings are historical filings (report dates Mar 31, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BME BlackRock Health Sciences Trust | Healthcare | 3.68% | $21.1M | 166,662 sh | $573M | 2.8% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 2.51% | $27.1M | 214,745 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund | Covered Call / Option Income | 1.37% | $21.8M | 172,825 sh | $1.6B | 3.3% discount | Jun 30, 2026 |
| ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | Covered Call / Option Income | 1.01% | $18.6M | 147,247 sh | $1.8B | 9.6% discount | Jun 30, 2026 |
| GAM General American Investors Co | U.S. Equity | 0.95% | $16.7M | 119,900 sh | $1.8B | 12.6% discount | Mar 31, 2026 |
| GLV Clough Global Dividend & Income Fund | Global Equity | 0.87% | $820K | 6,300 sh | $94.1M | 13.7% discount | Jul 31, 2026 |
| EVT Eaton Vance Tax-Advantaged Dividend Income Fund | U.S. Equity | 0.78% | $24M | 184,335 sh | $3.1B | 8.9% discount | Jul 31, 2026 |
| JCE Nuveen Core Equity Alpha Fund | U.S. Equity | 0.74% | $2.2M | 17,760 sh | $302M | 6.4% discount | Jun 30, 2026 |
| ETB Eaton Vance Tax-Managed Buy-Write Income Fund | Covered Call / Option Income | 0.62% | $3.1M | 24,351 sh | $495M | 10.4% discount | Jun 30, 2026 |
| ASG Liberty All Star Growth Fund | U.S. Equity | 0.39% | $1.5M | 12,170 sh | $398M | 13.5% discount | Jun 30, 2026 |
| CSQ Calamos Strategic Total Return Fund | Multi-Asset | 0.33% | $16.2M | 124,535 sh | $4.9B | 9.0% discount | Jul 31, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.33% | $758K | 6,000 sh | $228M | NAV unavailable | Jun 30, 2026 |
| ECAT BlackRock ESG Capital Allocation Term Trust | U.S. Equity | 0.23% | $3.8M | 30,328 sh | $1.7B | NAV unavailable | Jun 30, 2026 |
| HEQ John Hancock Diversified Income Fund | Multi-Asset | 0.19% | $307K | 2,428 sh | $163M | 9.7% discount | Jun 30, 2026 |
| BCAT BlackRock Capital Allocation Term Trust | U.S. Equity | 0.15% | $2.5M | 19,469 sh | $1.7B | NAV unavailable | Jun 30, 2026 |
| GAB Gabelli Equity Trust | U.S. Equity | 0.01% | $322K | 2,550 sh | $2.4B | 6.1% discount | Jun 30, 2026 |
| GOF Guggenheim Strategic Opportunities Fund | Multi-Asset | 0.00% | $16.9K | 126 sh | $2.8B | 11.2% discount | May 29, 2026 |
17 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: GILEAD SCIENCES INC; Gilead Sciences Inc.; Gilead Sciences, Inc..
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Gilead Sciences Inc | debt security | 2 |
| Gilead Sciences Inc | debt security | 1 |
| Gilead Sciences, Inc. | debt security | 1 |
| Gilead Sciences, Inc. | debt security | 1 |
| Gilead Sciences Inc | asset-backed security | 1 |
Issuer-level search for “GILD” → · Compare two funds’ portfolios →